Semaglutide is the active ingredient inside Ozempic. Ozempic is a brand name manufactured by Novo Nordisk, and semaglutide is the drug that makes it work. Think of it like ibuprofen and Advil: one is the medication itself, the other is the label on the box. But the story doesn’t end there, because semaglutide is also sold under other brand names for different purposes, and those differences matter.
Semaglutide Powers Several Brand-Name Drugs
Ozempic is FDA-approved specifically for managing type 2 diabetes. It also carries approvals for improving kidney and cardiovascular health in adults with type 2 diabetes. But the same molecule, semaglutide, is sold under other names with different approved uses. Wegovy, for instance, is FDA-approved for weight management in adults and children 12 and older, for treating a form of fatty liver disease in adults with moderate or advanced liver scarring, and for reducing cardiovascular risk in adults with obesity or overweight who also have heart disease.
There’s also an oral tablet version called Rybelsus, which delivers semaglutide in pill form rather than as an injection. Rybelsus is currently being rebranded as the “Ozempic pill.” All three products contain semaglutide, but because they’re approved for different conditions and come in different doses, they aren’t interchangeable without a prescription change.
How Semaglutide Works in Your Body
Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. It mimics a hormone your gut naturally releases after eating, triggering several effects at once. It boosts insulin release when your blood sugar is high (but not when it’s already normal, which reduces the risk of dangerous blood sugar drops). It dials back the release of glucagon, a hormone that raises blood sugar. And it slows the rate at which food leaves your stomach, which helps you feel full longer and reduces appetite.
These overlapping effects explain why semaglutide helps with both blood sugar control and weight loss. In clinical trials across the SUSTAIN program, people taking semaglutide saw their A1C levels drop by 0.6 to 1.6 percentage points more than people on comparator treatments. The cardiovascular benefits are also significant: in one large trial, semaglutide reduced the risk of major cardiovascular events by 26% compared to placebo.
Ozempic Dosing and How It’s Taken
Ozempic is a once-weekly injection given under the skin, on the same day each week, with or without food. You start at 0.25 mg per week, which is intentionally too low to have a therapeutic effect. That introductory dose exists to let your body adjust and minimize side effects, particularly nausea. After four weeks, the dose increases to 0.5 mg. From there, your doctor may raise it further based on your blood sugar response, up to a maximum of 2 mg per week.
The oral version (Rybelsus) works differently in terms of dosing. It’s taken daily rather than weekly, starting at 3 mg once a day for 30 days, then increasing to 7 mg, and potentially to 14 mg if blood sugar isn’t well controlled. A newer formulation uses slightly different strengths (1.5 mg, 4 mg, and 9 mg). Because the body absorbs oral semaglutide less efficiently than injected semaglutide, the daily pill doses are not directly comparable to the weekly injection doses.
Side Effects Tend to Hit Early
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. Most people who experience these symptoms do so within the first month of treatment. The risk decreases over time as your body adjusts, which is one reason the dose starts low and ramps up gradually.
There’s an interesting difference between the two delivery methods. Oral semaglutide is more likely to cause gastrointestinal problems, while the injectable form is more likely to trigger endocrine-related side effects. Both routes show what researchers describe as an “early failure” pattern, meaning adverse events cluster at the beginning of treatment and taper off.
What Ozempic Costs
The list price for an Ozempic pen is about $1,028. For patients paying out of pocket, Novo Nordisk offers a program that brings the cost to $199 per month for the first two months (covering the 0.25 mg and 0.5 mg starter doses). After that, the standard self-pay price is $349 per month for doses up to 1 mg, or $499 per month for the 2 mg dose. Insurance coverage varies widely, and many plans cover Ozempic for type 2 diabetes but not for weight loss, since it isn’t FDA-approved for that purpose.
Compounded Semaglutide Is Not the Same
Some compounding pharmacies sell their own versions of semaglutide at lower prices, but these products carry real risks. The FDA has warned that some compounded versions use salt forms of semaglutide, such as semaglutide sodium or semaglutide acetate, which are chemically different from the active ingredient in approved products. The FDA has stated that it does not have information on whether these salt forms share the same chemical and pharmacologic properties as the semaglutide in Ozempic or Wegovy, and it is not aware of any lawful basis for using them in compounding.
This is not a technicality. A different salt form could absorb differently, break down differently, or behave unpredictably in your body. If you’re considering a compounded version to save money, the cost savings come with uncertainty about what you’re actually getting.